Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2015

01-06-2015 | Original Paper

Positive Transitions (POST): Evaluation of an HIV Prevention Intervention for HIV-Positive Persons Releasing from Correctional Facilities

Authors: Robin J. MacGowan, Julie Lifshay, Yuko Mizuno, Wayne D. Johnson, Lyle McCormick, Barry Zack

Published in: AIDS and Behavior | Issue 6/2015

Login to get access

Abstract

People with HIV who are released from custody frequently do not maintain the viral suppression and other health benefits achieved while incarcerated. This study was conducted to provide preliminary evidence of efficacy of an intervention to reduce HIV risk behaviors and increase use of HIV medical services following release from custody. People with HIV were recruited from San Francisco County jails, San Quentin State Prison and the California Medical Facility (Vacaville, CA), and randomly assigned to the “standard of care” or POST intervention. POST consisted of 4 sessions pre-release and 2 sessions post-release, focusing on HIV prevention and access to care. Behavioral data were obtained for the 3 months before incarceration and 3 months after release. Although POST participants reported a statistically significant increase in receiving health care at HIV clinics (62.5–84.4 %), there were no significant differences between the POST and control participants with respect to any primary outcomes.
Literature
1.
2.
Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997;337(11):734–9.PubMedCrossRef
3.
Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–60.PubMedCrossRef
4.
Porter K, Babiker A, Bhaskaran K, et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003;362(9392):1267–74.PubMedCrossRef
5.
Hogg RS, Yip B, Kully C, et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ. 1999;160(5):659–65.PubMedCentralPubMed
6.
Ray M, Logan R, Sterne JA, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2010;24(1):123–37.PubMedCrossRef
7.
8.
Office of National AIDS Policy. National HIV/AIDS Strategy for the United States: The White House; July 2010.
9.
Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009;4(11):e7558.PubMedCentralPubMedCrossRef
10.
MacGowan R, Margolis A, Richardson-Moore A, et al. Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sex Transm Dis. 2009;36(2 Suppl):S9–13.PubMedCrossRef
11.
CDC. HIV screening of male inmates during prison intake medical evaluation—Washington, 2006–2010. MMWR. 2011;60(24):811–3.
12.
VanHandel M, Beltrami JF, MacGowan RJ, Borkowf CB, Margolis AD. Newly identified HIV infections in correctional facilities, United States, 2007. Am J Public Health. 2012;102(Suppl 2):S201–4.PubMedCentralPubMedCrossRef
13.
14.
CDC. Routine Jail-Based HIV Testing—Rhode Island, 2000–2007. MMWR. 2010;25(24):742–5.
15.
CDC. Routine HIV screening during intake medical evaluation at a county jail—fulton county, georgia, 2011–2012. MMWR. 2013;62(24):495–7.
16.
Maruschak LM. HIV In Prisons, 2001–2010. Bureau of Justice Statistics Bulletin: U.S. Department of Justice; 2012.
17.
Springer S, Friedland G, Doros G, Pesanti E, Altice F. Antiretroviral Treatment Regimen Outcomes Among HIV-Infected Prisoners. HIV Clin Trials. 2007;8(4):205–12.PubMedCentralPubMedCrossRef
18.
Baillargeon JG, Giordano TP, Harzke AJ, Baillargeon G, Rich JD, Paar DP. Enrollment in outpatient care among newly released prison inmates with HIV infection. Public Health Rep. 2010;125(1):64–71.PubMedCentralPubMed
19.
Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120(1):84–8.PubMedCentralPubMed
20.
Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–60.PubMedCrossRef
21.
22.
Pant Pai N, Estes M, Moodie EEM, Reingold AL, Tulsky JP. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco County Jail. PLoS One. 2009;4(9):e7115.PubMedCentralCrossRef
23.
National Commission on Correctional Health Care. Standards for Health Services in Prisons. Chicago: National Commission on Correctional Health Care; 2008.
24.
National Commission on Correctional Health Care. Standards for Health Services in Jails. Chicago: National Commission on Correctional Health Care; 2008.
25.
26.
Fontana L, Beckerman A. Recently released with HIV/AIDS: primary care treatment needs and experiences. J Health Care Poor Underserved. 2007;18(3):699–714.PubMedCrossRef
27.
Baillargeon J, Giordano TP, Harzke AJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010;24(6):389–94.PubMedCentralPubMedCrossRef
28.
29.
Grinstead O, Zack B, Faigeles B. Reducing postrelease risk behavior among HIV seropositive prison inmates: the health promotion program. AIDS Educ Prev. 2001;13(2):109–19.PubMedCrossRef
30.
Reznick OG, McCartney K, Gregorich SE, Zack B, Feaster DJ. An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community. J Correct Health Care. 2013;19(3):178–93.PubMedCentralPubMedCrossRef
31.
32.
MacGowan R, Eldridge G, Sosman J, et al. HIV counseling and testing of young men in prison. J Correct Health Care. 2006;12(3):203–13.CrossRef
33.
Wolitski RJ. Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states. Am J Public Health. 2006;96(10):1854–61.PubMedCentralPubMedCrossRef
34.
Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.PubMedCrossRef
35.
Vallabhaneni S, McConnell JJ, Loeb L, et al. Changes in Seroadaptive Practices from before to after Diagnosis of Recent HIV Infection among Men Who Have Sex with Men. PLoS One. 2013;8(2):e55397.PubMedCentralPubMedCrossRef
36.
Steward WT, Remien RH, Higgins JA, et al. Behavior change following diagnosis with acute/early HIV infection-a move to serosorting with other HIV-infected individuals. The NIMH Multisite Acute HIV Infection Study: III. AIDS Behav. 2009;13(6):1054–60.PubMedCentralPubMedCrossRef
37.
Harzke AJ, Ross MW, Scott DP. Predictors of post-release primary care utilization among HIV-positive prison inmates: a pilot study. AIDS Care. 2006;18(4):290–301.PubMedCrossRef
38.
Johnson A, Hall H, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of hiv infection in the united states, 2002–2011. JAMA. 2014;312(4):432–4.PubMedCrossRef
Metadata
Title
Positive Transitions (POST): Evaluation of an HIV Prevention Intervention for HIV-Positive Persons Releasing from Correctional Facilities
Authors
Robin J. MacGowan
Julie Lifshay
Yuko Mizuno
Wayne D. Johnson
Lyle McCormick
Barry Zack
Publication date
01-06-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0879-8

Other articles of this Issue 6/2015

AIDS and Behavior 6/2015 Go to the issue

Original Paper

Neighborhood Condition and Geographic Locale in Assessing HIV/STI Risk Among African American Adolescents

Original Paper

Association of Markers of Inflammation with Sleep and Physical Activity Among People Living with HIV or AIDS

Brief Report

Correlates of Individual Versus Joint Participation in Online Survey Research with Same-Sex Male Couples

Original Paper

A Longitudinal Investigation of Syndemic Conditions Among Young Gay, Bisexual, and Other MSM: The P18 Cohort Study

Original Paper

Psychosocial Syndemics are Additively Associated with Worse ART Adherence in HIV-Infected Individuals

Original Paper

Changes in Exposure to Neighborhood Characteristics are Associated with Sexual Network Characteristics in a Cohort of Adults Relocating from Public Housing
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits